These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1574542)

  • 21. Serum growth hormone levels in schizophrenic patients during sleep.
    Syvälahti E; Pekkarinen A
    J Neural Transm; 1977; 40(3):221-6. PubMed ID: 874474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prolactin and growth hormone responses to growth hormone-releasing hormone in acute schizophrenia.
    Nerozzi D; Magnani A; Sforza V; Scaramucci E; Cerilli M; Moretti C; Antonozzi I; Frajese G
    Neuropsychobiology; 1990; 23(1):15-7. PubMed ID: 2280826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nocturnal secretion of growth hormone, noradrenaline, cortisol and insulin in cluster headache remission.
    Meyer EL; Marcus C; Waldenlind E
    Cephalalgia; 2007 Aug; 27(8):912-9. PubMed ID: 17645758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperdopaminergia in schizophreniform psychosis: a chronobiological study.
    Rao ML; Gross G; Halaris A; Huber G; Marler M; Strebel B; Bräunig P
    Psychiatry Res; 1993 May; 47(2):187-203. PubMed ID: 8341771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered nocturnal growth hormone (GH) secretion in obsessive compulsive disorder.
    Kluge M; Schüssler P; Weikel J; Dresler M; Zuber V; Querfurt F; Yassouridis A; Steiger A
    Psychoneuroendocrinology; 2006 Oct; 31(9):1098-104. PubMed ID: 16965859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A method to evaluate dynamics and periodicity of hormone secretion.
    Mazzoccoli G; Giuliani F; Sothern RB
    J Biol Regul Homeost Agents; 2011; 25(2):231-8. PubMed ID: 21880212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relation of clinical symptoms to apomorphine-stimulated growth hormone release in mood-incongruent psychotic patients.
    Zemlan FP; Hirschowitz J; Garver DL
    Arch Gen Psychiatry; 1986 Dec; 43(12):1162-7. PubMed ID: 3778112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced growth hormone response to apomorphine in schizophrenic patients with poor premorbid social functioning.
    Malas KL; van Kammen DP; de Fraites EA; Brown GM; Gold PW
    J Neural Transm; 1987; 69(3-4):319-24. PubMed ID: 3625198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of moderate weight loss on overnight growth hormone and cortisol secretion in healthy female volunteers.
    Anderson IM; Crook WS; Gartside SE; Fairburn CG; Cowen PJ
    J Affect Disord; 1989; 16(2-3):197-202. PubMed ID: 2522119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth hormone response to sodium valproate in chronic schizophrenia.
    Monteleone P; Maj M; Iovino M; Steardo L
    Biol Psychiatry; 1986 Jun; 21(7):588-94. PubMed ID: 3085738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute effect of intravenous clomipramine upon sleep-related hormone secretion in depressed outpatients and healthy control subjects.
    Jarrett DB; Pollock B; Miewald JM; Kupfer DJ
    Biol Psychiatry; 1991 Jan; 29(1):3-14. PubMed ID: 2001445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circadian patterns of cortisol, prolactin, and growth hormonal secretion during bingeing and vomiting in normal weight bulimic patients.
    Weltzin TE; McConaha C; McKee M; Hsu LK; Perel J; Kaye WH
    Biol Psychiatry; 1991 Jul; 30(1):37-48. PubMed ID: 1892960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Age-dependent suppression of nocturnal growth hormone levels during sleep deprivation.
    Mullington J; Hermann D; Holsboer F; Pollmächer T
    Neuroendocrinology; 1996 Sep; 64(3):233-41. PubMed ID: 8875441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The neuroendocrinological profile of roxindole, a dopamine autoreceptor agonist, in schizophrenic patients.
    Gründer G; Wetzel H; Hillert A; Jochum E; Hiemke C; Benkert O
    Psychopharmacology (Berl); 1995 Feb; 117(4):472-8. PubMed ID: 7604150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Failure of postictal growth hormone rise in a patient with thalamic lesions.
    Culebras A; Miller M
    Neurology; 1985 Jun; 35(6):904-7. PubMed ID: 4039805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thirty-second sampling of plasma growth hormone in man: correlation with sleep stages.
    Holl RW; Hartman ML; Veldhuis JD; Taylor WM; Thorner MO
    J Clin Endocrinol Metab; 1991 Apr; 72(4):854-61. PubMed ID: 2005213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Spontaneous secretion of growth hormone in deep nocturnal sleep. II. Studies on hypophyseal dwarfism and constitutional developmental delay].
    Bierich JR; Brügmann G; Kiessling E
    Monatsschr Kinderheilkd; 1989 Feb; 137(2):80-5. PubMed ID: 2716742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of short-and long-term corticosteroid treatment on sleep-associated growth hormone secretion.
    Motson RW; Glass DN; Smith DA; Daly JR
    Clin Endocrinol (Oxf); 1978 Apr; 8(4):315-26. PubMed ID: 647985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship of plasma growth hormone to slow-wave sleep in African sleeping sickness.
    Radomski MW; Buguet A; Doua F; Bogui P; Tapie P
    Neuroendocrinology; 1996 Apr; 63(4):393-6. PubMed ID: 8739895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth hormone response to TRH in families multiply affected with schizophrenia.
    Sirota P; Gil-Ad I; Hermesh H; Munitz H; Laron Z; Weizman R
    Biol Psychiatry; 1992 Jun; 31(12):1241-4. PubMed ID: 1391288
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.